PACTR202306748777678已完成Unknown
The effects of Midodrine on patients with liver cirrhosis and refractory ascites
tanta university hospital0 个研究点目标入组 80 人开始时间: 2023年6月13日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)（—）
- 性别
- All
入选标准
- •Cirrhotic patients more than 18 years
- •Cirrhosis secondary to any etiology.
- •Cirrhosis was diagnosed by US evaluation.
- •2-Patients with refractory ascites.
- •The willing to sign informed consent and ready for regular follow-up during the study.
排除标准
- •Patients with acute or chronic renal disease.
- •Patients with cardiac disease:
- •1-Coronary heart disease.
- •2-Abnormal blood pressure.
- •3-Congestive heart failure.
- •Hepatocellular carcinoma.
- •Portal vein thrombosis.
研究者
相似试验
Unknown
不适用
Safety and Efficacy of Midodrine Hydrochloride in the Management of Refractory Ascites Due to Cirrhosis in ChildrenRefractory AscitesChildren, OnlyNCT04043858National Liver Institute, Egypt20
已完成
早期 1 期
Midodrine and refractory gastroesophageal diseaseIRCT201402274226N2Shiraz University of Medical Sciences60
已完成
4 期
Effect of Midodrine and Albumine in the Prevention of Complications in Cirrhotic Patients Awaiting Liver TransplantationSepsisHyponatremiaRenal FailureHepatic EncephalopathyGastrointestinal BleedingNCT00839358Hospital Clinic of Barcelona199
已完成
不适用
Effect of Midodrine (drug) in liver diseaseCTRI/2020/07/026404Institute of Liver and Biliary Sciences60
招募中
不适用
To Study Effect of the Combination of Midodrine and Tolvaptan (drug) Versus Tolvaptan Alone in Patients With Severe Hyponatremia in Cirrhosis (Liver Disease).CTRI/2021/09/036265Institute of Liver and Biliary Sciences